Goldman Sachs’s Hinge Health HNGE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$83.9M Buy
1,011,256
+722,231
+250% +$39.2M 0.01% 1367
2026
Q1
$11.1M Sell
289,025
-302,686
-51% -$12.6M ﹤0.01% 2983
2025
Q4
$27.5M Buy
591,711
+279,998
+90% +$13.5M ﹤0.01% 2068
2025
Q3
$15.3M Buy
311,713
+120,304
+63% +$6.29M ﹤0.01% 2531
2025
Q2
$9.91M Buy
+191,409
New +$7.74M ﹤0.01% 2763

Other funds holding HNGE

Goldman Sachs's HNGE Position: Q2 2026 in Review

Goldman Sachs increased its Hinge Health (HNGE) stake by 250% in Q2 2026, buying an estimated $39.2M and bringing the position to 1,011,256 shares worth $83.9M. The position accounts for 0.01% of the portfolio, ranked #1367.

Goldman Sachs first reported a position in HNGE in Q2 2025 and has held it in 5 quarters since. 276 funds tracked by Wall St. Rank hold HNGE as of Q2 2026.

  • Goldman Sachs held 1,011,256 shares of Hinge Health worth $83.9M as of Q2 2026.
  • Goldman Sachs bought 722,231 Hinge Health shares in Q2 2026, an estimated $39.2M.
  • Hinge Health made up 0.01% of Goldman Sachs's portfolio in Q2 2026, its #1367 holding.
  • Goldman Sachs first reported a position in Hinge Health in Q2 2025 and has held it in 5 quarters since.
  • 276 funds tracked by Wall St. Rank held Hinge Health as of Q2 2026.

Based on Goldman Sachs's 13F filing for Q2 2026, filed 14 Aug 2026.